Federation des caisses Desjardins du Quebec’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-130	Closed	-$3.27K	–	2562
2022 Q3	$3.27K	Hold	130	–	–	﹤0.01%	2169
2022 Q2	$3.95K	Hold	130	–	–	﹤0.01%	2182
2022 Q1	$4.26K	Hold	130	–	–	﹤0.01%	2233
2021 Q4	$3.43K	Buy	130 +70	+117%	+$5.42K	﹤0.01%	2288
2021 Q3	$6.04K	Buy	+60	New	+$7.03K	﹤0.01%	2188

Other funds holding RETA

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's RETA Position: Q4 2022 in Review

Federation des caisses Desjardins du Quebec sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q4 2022, closing a stake of 130 shares — an estimated $3.27K sold.

Federation des caisses Desjardins du Quebec first reported a position in RETA in Q3 2021 and held it in 5 quarters. The position peaked at $6.04K in Q3 2021. 168 funds tracked by Wall St. Rank hold RETA as of Q4 2022.

Federation des caisses Desjardins du Quebec reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 130 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q4 2022, an estimated $3.27K.
Federation des caisses Desjardins du Quebec first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2021 and held it in 5 quarters.
Federation des caisses Desjardins du Quebec's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $6.04K in Q3 2021.
168 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q4 2022.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2022, filed 15 Aug 2024.